MicroPulse laser therapy is a tissue-sparing solution for the treatment of retinal diseases and glaucoma. With MicroPulse, a continuous-wave laser beam is chopped into a train of short, repetitive, low energy pulses separated by a brief rest period which eliminates the risk of damage to photoreceptors and at the same time stimulates cells of retina and choroid to release anti-inflammatory factors.

MicroPulse laser therapy is highly efficient  in the treatment of retina diseases that affect the most important zone of the fundus – the macula. In some cases when conventional laser or vitreoretinal surgery is contraindicated due to the risk of retinal damage such therapy is the only treatment option to preserve the pathology progression and to restore visual functions.

Navigated laser photocoagulation is a novel technique that significantly increases safety of laser treatment. Navigated photocoagulation means that laser burns can be precisely applied to retina directly in the pathology zone in automatic mode after pre-planning. This is especially useful in focal photocoagulation technique where the exact location and targeting of diabetic microaneurysms, for instance, is of crucial importance. Another advantage of this laser system is the possibility of non-contact photocoagulation. This unique feature allows to significantly simplify the treatment process and increase patient’s satisfaction.

Laser vitreolysis is a minimally invasive procedure that can significantly improve a patient’s perception of their everyday visual functionality and provide them with much-needed relief from annoying eye floaters. The technique fills the treatment gap for patients whose symptoms and risk profile does not warrant treatment with vitrectomy. Laser Floater Treatment can also delay or obviate the need for surgery. The gain of visual functions can be achieved immediately after the laser procedure and results in significant improvement of the patient’s life quality.

Photodynamic therapy (PDT) is a therapeutic technique involving the use of a photosensitising agent that produces selective tissue damage when activated by light of a specific wavelength. This treatment option is successfully used in cases of wet age-related macular degeneration, central serous chorioretinopathy and tumors.